New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.

[1]  F. Pinguet,et al.  In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. , 2008, Bioorganic & medicinal chemistry.

[2]  Y. Kfoury,et al.  EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma. , 2008, Blood.

[3]  Ping Chen,et al.  Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity. , 2004, Journal of medicinal chemistry.

[4]  D. Sauder,et al.  Imiquimod: modes of action , 2003 .

[5]  James R. Burke,et al.  BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice* , 2003, The Journal of Biological Chemistry.

[6]  B. Bonnekoh,et al.  Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma , 2002, Dermatology.

[7]  D. Schadendorf,et al.  Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene mgmt , 2001, International journal of cancer.

[8]  J. Vidal,et al.  Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity. , 2001, European journal of medicinal chemistry.

[9]  G. Schuler,et al.  Topical imiquimod treatment of a cutaneous melanoma metastasis. , 2000, Journal of the American Academy of Dermatology.

[10]  R. Miller,et al.  Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways , 1995, Molecular and cellular biology.

[11]  Richard L. Miller,et al.  Cytokine induction in mice by the immunomodulator imiquimod , 1994, Journal of leukocyte biology.

[12]  M. Inbar,et al.  Fotemustine — an advance in the treatment of metastatic malignant melanoma , 1992, Melanoma research.

[13]  M J Reiter,et al.  Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. , 1992, Cancer research.